TR200000907T2 - Nötrofil elastaz inhibitörleri olarak pirolopirolon türevleri. - Google Patents

Nötrofil elastaz inhibitörleri olarak pirolopirolon türevleri.

Info

Publication number
TR200000907T2
TR200000907T2 TR2000/00907T TR200000907T TR200000907T2 TR 200000907 T2 TR200000907 T2 TR 200000907T2 TR 2000/00907 T TR2000/00907 T TR 2000/00907T TR 200000907 T TR200000907 T TR 200000907T TR 200000907 T2 TR200000907 T2 TR 200000907T2
Authority
TR
Turkey
Prior art keywords
pyrolopirolone
derivatives
neutrophil elastase
elastase inhibitors
compounds
Prior art date
Application number
TR2000/00907T
Other languages
English (en)
Inventor
Duke Edward Clarke Geoffrey
Dennis Dowle Michael
Finch Harry
Andrew Harrison Lee
George Adam Inglis Graham
Redpath Johnson Martin
John Fawcett Macdonald Simon
Shah Pritom
Andrew Smith Robin
Original Assignee
Glaxo Group Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9719189.4A external-priority patent/GB9719189D0/en
Priority claimed from GBGB9719183.7A external-priority patent/GB9719183D0/en
Priority claimed from GBGB9719290.0A external-priority patent/GB9719290D0/en
Priority claimed from GBGB9803611.4A external-priority patent/GB9803611D0/en
Application filed by Glaxo Group Limited filed Critical Glaxo Group Limited
Publication of TR200000907T2 publication Critical patent/TR200000907T2/tr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Hydrogenated Pyridines (AREA)

Abstract

Bu bulusa göre (I) formülünün bilesikleri temin edilmektedir, bu formülde, R1,R2,ve R3 tarifnamede tanimlandigi gibidir. (I) formülü bilesikleri, diger yararlarinin yaninda, solunum yolunun ihtihapli bozukluklarinin tedavisinde yararli olmaktadir.
TR2000/00907T 1997-09-09 1998-09-07 Nötrofil elastaz inhibitörleri olarak pirolopirolon türevleri. TR200000907T2 (tr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GBGB9719189.4A GB9719189D0 (en) 1997-09-09 1997-09-09 New therapeutic method
GBGB9719183.7A GB9719183D0 (en) 1997-09-09 1997-09-09 Compounds
GBGB9719290.0A GB9719290D0 (en) 1997-09-10 1997-09-10 Compounds
GBGB9803611.4A GB9803611D0 (en) 1998-02-21 1998-02-21 Compounds

Publications (1)

Publication Number Publication Date
TR200000907T2 true TR200000907T2 (tr) 2000-11-21

Family

ID=27451698

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2000/00907T TR200000907T2 (tr) 1997-09-09 1998-09-07 Nötrofil elastaz inhibitörleri olarak pirolopirolon türevleri.

Country Status (24)

Country Link
EP (1) EP1003748A2 (tr)
JP (1) JP2001515904A (tr)
KR (1) KR20010023766A (tr)
CN (1) CN1278820A (tr)
AP (1) AP2000001761A0 (tr)
AR (1) AR017072A1 (tr)
AU (1) AU9741298A (tr)
BR (1) BR9812062A (tr)
CA (1) CA2303176A1 (tr)
CO (1) CO4970719A1 (tr)
EA (1) EA200000204A1 (tr)
EE (1) EE200000138A (tr)
HU (1) HUP0004644A3 (tr)
ID (1) ID24452A (tr)
IL (1) IL134791A0 (tr)
IS (1) IS5391A (tr)
MA (1) MA26543A1 (tr)
NO (1) NO20001198L (tr)
NZ (1) NZ503130A (tr)
PE (1) PE107899A1 (tr)
PL (1) PL339176A1 (tr)
SK (1) SK3192000A3 (tr)
TR (1) TR200000907T2 (tr)
WO (1) WO1999012933A2 (tr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9905418D0 (en) * 1999-03-09 1999-05-05 Glaxo Group Ltd Process
MXPA06011410A (es) 2004-03-31 2007-04-20 Johnson & Johnson Compuestos heterociclicos sin imidazol como moduladores de receptor de histamina h3.
DE102004024772A1 (de) * 2004-05-17 2005-12-22 Grünenthal GmbH Substituierte 5-Aminomethyl-1H-pyrrol-2-carbonsäureamide
JP4853759B2 (ja) * 2004-05-27 2012-01-11 日本農薬株式会社 置換ピラジンカルボン酸アニリド誘導体又はその塩類、その中間体及び農園芸用薬剤並びにその使用方法
TWI355380B (en) * 2004-05-27 2012-01-01 Nihon Nohyaku Co Ltd Substituted pyrazinecarboxanilide derivatives or s
GB2418427A (en) 2004-09-02 2006-03-29 Univ Cambridge Tech Ligands for G-protein coupled receptors
ES2328384T3 (es) 2004-11-23 2009-11-12 Warner-Lambert Company Llc Derivados del acido 7-(2h-pirazol-3-il)-3,5-dihidroxi-heptanoico como inhibidores de hmg co-a reductasa para el tratamiento de la lipidemia.
US8198288B2 (en) 2006-05-04 2012-06-12 Pulmagen Therapeutics (Inflammation) Limited Tetrahydropyrrolopyrimidinediones and their use in therapy
DK2024367T3 (da) 2006-05-04 2011-01-03 Pulmagen Therapeutics Inflammation Ltd Tetrahydropyrrolopyrimidindioner og deres anvendelse som inhibitorer af human neutrofil elastase
US7662967B2 (en) 2007-08-02 2010-02-16 Cambridge Enterprise Limited Anti-inflammatory compounds and compositions
GB2452696B (en) 2007-08-02 2009-09-23 Cambridge Entpr Ltd 3-(2',2'-dimethylpropanoylamino)-tetrahydropyridin-2-one and its use in pharmaceutical compositions
WO2009060206A1 (en) * 2007-11-07 2009-05-14 Argenta Discovery Limited 3,4,6,7-tetrahydro-1h-pyrrolo[3,4-d]pyrimidine-2,5-diones and their therapeutic use
US20110212181A1 (en) * 2010-02-26 2011-09-01 The University Of Hong Kong Compositions and methods for treating chronic respiratory inflammation
AU2020349353A1 (en) 2019-09-17 2022-04-14 Duke University Alvelestat for use in the treatment of graft rejection, bronchiolitis obliterans syndrome and graft versus host disease
HUE064089T2 (hu) 2020-04-16 2024-02-28 Mereo Biopharma 4 Ltd Alvelesztat neutrofil elasztáz inhibitort alkalmazó módszerek alfa-1-antitripszin hiány által közvetített légzõszervi megbetegedés kezelésére
AU2022373971A1 (en) 2021-10-20 2024-04-04 Mereo Biopharma 4 Limited Neutrophil elastase inhibitors for use in the treatment of fibrosis

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9211783D0 (en) * 1992-06-04 1992-07-15 Ici Plc Amide derivatives
GB9402680D0 (en) * 1994-02-11 1994-04-06 Zeneca Ltd Pyrrolidine derivatives
IL125859A0 (en) * 1996-03-28 1999-04-11 Glaxo Group Ltd Pyrrolopyrrolone derivatives useful as inhibitors of neutrophil elastase

Also Published As

Publication number Publication date
WO1999012933A2 (en) 1999-03-18
ID24452A (id) 2000-07-20
BR9812062A (pt) 2000-09-26
HUP0004644A3 (en) 2002-01-28
IS5391A (is) 2000-02-29
EE200000138A (et) 2001-02-15
CN1278820A (zh) 2001-01-03
CA2303176A1 (en) 1999-03-18
CO4970719A1 (es) 2000-11-07
EP1003748A2 (en) 2000-05-31
SK3192000A3 (en) 2001-03-12
WO1999012933A3 (en) 1999-05-27
NO20001198D0 (no) 2000-03-08
NZ503130A (en) 2001-08-31
NO20001198L (no) 2000-05-08
HUP0004644A2 (hu) 2001-09-28
EA200000204A1 (ru) 2000-10-30
AP2000001761A0 (en) 2000-03-31
IL134791A0 (en) 2001-04-30
AR017072A1 (es) 2001-08-22
PL339176A1 (en) 2000-12-04
KR20010023766A (ko) 2001-03-26
AU9741298A (en) 1999-03-29
JP2001515904A (ja) 2001-09-25
MA26543A1 (fr) 2004-12-20
PE107899A1 (es) 1999-11-17

Similar Documents

Publication Publication Date Title
DE69823344D1 (de) Substituierte benzimidazol-derivaten und ihre verwendung zur behandlung retroviraler infektionen
DE60036726D1 (de) Harnstoff derivate als entzündungshemmende mittel
TR199901905T2 (tr) 2-(Pürin-9-il)-tetrahidrofuran-3,4-diol türevleri.
ES2196396T3 (es) Compuestos heteroaromaticos de 5 miembros conteniendo oxigeno o azufre como inhibidores del factor xa.
ATE269312T1 (de) N-(amidinophenyl)-n'-(subst.)-3h-2,4- benzodiazepin-3-on derivative als faktor xa inhibitoren
ATE230392T1 (de) Amidinophenyl-pyrrolidine, -pyrroline und - isoxazolidine und ihre derivate
TR200000059T2 (tr) Piridin türevleri
FI970246A7 (fi) Dihydrobentsofuraanit
TR200100805T2 (tr) Tetrahidropiridoeterler
TR200101709T2 (tr) İltihabik hastalıkların tedavisinde yararlı olan bileşikler
TR200101499T1 (tr) Azepinoindol türevleri, hazırlanmaları ve kullanımları.
TR200201505T2 (tr) Terapötik maddeler olarak pirazolopirimidinler
ATE277929T1 (de) Immunsuppressive wirkungen von pteridinderivaten
EE200000033A (et) Uudsed tetrasoolderivaadid
IT1285770B1 (it) Composti corticoidei
AP2000001761A0 (en) Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase.
EP1171428A4 (en) FAB-I INHIBITORS
ATE303384T1 (de) 1-biaryl-1,8-naphthyridin-4-one als phosphodieseterase-inhibitoren
DE69821530D1 (de) Dihydrobenzifurane
ATE311389T1 (de) Wirkstoffvorläufer von imidazopyridin-derivaten
TR200201128T2 (tr) PDE4 inhibitörleri olarak tetrahidrotiyopiranfitalazinon türevleri.
FI970469A0 (fi) Bentsimidatsolijohdannaisia, joilla on dopaminerginen aktiivisuus
SE9903290D0 (sv) Novel compounds
DK1377574T3 (da) 6-phenylbenzonaphtyridiner
AP2000001760A0 (en) Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase.